Einstein/Montefiore Department of Medicine

Grand Rounds

Diabetes and Bartleby the Scrivener

Einstein/Montefiore Department of Medicine Grand Rounds

Thursday, April 30, 2015

8:00 AM: Forchheimer Medical Science Building 3rd Floor Lecture Hall

Speaker & Info

Clay F. Semenkovich, MD
Herbert S. Gasser Professor
Chief, Division of Endocrinology, Metabolism & Lipid Research
Professor of Medicine and of Cell Biology and Physiology
Washington University in St. Louis School of Medicine
Endocrinologist-in-Chief, Barnes-Jewish Hospital
Co-Director, Diabetes Research Center, Washington University

Repeated at 12:15 pm, Cherkasky Auditorium, Montefiore Medical Center.

An active educator and clinician, Dr. Clay Semenkovich has won numerous teaching awards, founded the Washington University Diabetes Center at Barnes-Jewish Hospital to provide comprehensive outpatient clinical care to people with diabetes in the St. Louis region, established a comprehensive Pituitary Center at Barnes Jewish Hospital in collaboration with the neurosurgery service, and expanded consultative inpatient diabetes services at Barnes-Jewish Hospital to improve care and decrease the complications of insulin therapy.

Dr. Semenkovich is the author of more than 150 original articles and reviews, and contributes the current chapters on disorders of lipid metabolism to both the Cecil Textbook of Medicine and Williams Textbook of Endocrinology. His lab has pursued interactions between diabetes, obesity, lipid metabolism, and atherosclerosis for 25 years, and has made several key observations with translational relevance. He has trained dozens of investigators, many of whom have had successful careers in academia and industry, an activity enhanced by his founding of the NIH Building Interdisciplinary Research Careers in Women's Health (BIRCWH) program at Washington University, and his direction of the NIH diabetes training grant at Washington University. He has chaired several American Diabetes Association Committees, contributed to the diabetes community through service at NIH, is a member of the editorial boards for the Journal of Lipid Research, the Journal of Clinical Investigation, and Cell Metabolism, and was elected to the American Society for Clinical Investigation and the Association of American Physicians.

Dr. Semenkovich was educated at the University of Virginia and Washington University in St. Louis. He trained in internal medicine then endocrinology at Washington University, joined the faculty at the Baylor College of Medicine, then returned to Washington University where he rose to his current positions as the Herbert S. Gasser Professor, Chief of the Division of Endocrinology, Metabolism, and Lipid Research, Endocrinologist-in-Chief at Barnes-Jewish Hospital, and Co-Director of the Diabetes Research Center at Washington University.

Objectives - After attending this activity, participants will be able to:

  1. Genetic variants related to the metabolic syndrome and type 2 diabetes may impact patient care
  2. Statins modestly increase diabetes risk but benefits from their use outweigh that risk
  3. PSCK9 inhibitors may soon be available

Accreditation: Albert Einstein College of Medicine designates this educational activity for a maximum of 1 credit towards the AMA Physician's Recognition Award. Each physician should claim only those credits that he/she actually spent in the educational activity.

Host: Division of Endocrinology & Diabetes (Department of Medicine)

Contact Us

Department of Medicine
Albert Einstein College of Medicine
Jack and Pearl Resnick Campus
Belfer Building - Room 1008
1300 Morris Park Avenue
Bronx, NY 10461 (directions)

Physicians and Patients:
866-MED-TALK (866-633-8255)

Internal Medicine Residency Program:

Administrative Questions:
Fax: 718-430-8659

Click here to log in